France Bans Oral Nicotine Products in Forms of Pouches, Pastes, Tablets, and Liquids Starting March 2026

Sep.08.2025
France Bans Oral Nicotine Products in Forms of Pouches, Pastes, Tablets, and Liquids Starting March 2026
France's Decree No. 2025-898 bans all oral nicotine products nationwide six months after publication. Medicines and medical devices are exempt. This includes nicotine pouches, gum, lozenges, and other forms, regardless of origin. The decree is based on the Public Health Code and applies to mainland France and Wallis and Futuna Islands.

Key Points:

 

·Ban Scope: The production, manufacture, transport, import, export, possession, offer/sale, purchase, and use of these products are prohibited within France.

·Formats include: nicotine pouches (including porous pouches), pastes, beads, liquids, chewing gum, lozenges, films/strips, etc. (regardless of whether the nicotine is natural or synthetic).

·Exemptions:
1. Chewing tobacco;
2. Legally approved pharmaceuticals, medical devices, and their medicinal raw materials;
3. Food (naturally containing trace amounts of nicotine or meeting EU pesticide residue limits).

·Research Exceptions: Case-by-case exemptions for research purposes may be issued by the Minister of Health, subject to separate conditions and procedures.

·Effective Date: Le Monde and Radio France Internationale reported that the ban will officially take effect in March 2026.

 


 

2Firsts, September 8, 2025 - According to the French government's official website on September 5, the French government published Decree No. 2025-898 in the Official Gazette, which will take effect six months from its publication. This ban applies nationwide to the production, sale, possession, purchase, and use of "nicotine-containing products for oral use," with the exception of medicines and medical devices.

 

The decree specifies that the ban covers all stages of the process: production, manufacturing, transportation, import/export, possession, provision/transfer, purchase, and actual use.

 

Formats subject to the ban include:

 

Nicotine pouches (including porous pouches), pastes, beads, liquids, chewing gum, lozenges, films/strips, and more (regardless of whether the nicotine is natural or synthetic).

 

Exemptions include:

 

·Chewing tobacco;

·Legally approved medicines, medical devices, and their medicinal raw materials;

·Food (naturally containing nicotine or meeting EU pesticide residue limits).

 

The decree provides for scientific research exceptions, which can be granted for specific research projects upon the signature of the Minister of Health and in compliance with specified conditions.

 

The background document states that nicotine is classified as a "toxic substance" under the French Public Health Code, allowing for a ban on "any related operation" by decree of the Council of State. The decree has also been submitted to the European Union for technical regulatory information (notification number 2025/0110/FR) as required.

 

The decree indicates that, in addition to mainland France, the relevant provisions also apply to the Wallis and Futuna Islands.

 

Le Monde and Radio France Internationale reported that the ban will officially take effect in March 2026.

 

Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
French vaping company Kumulus Vape reported first-half 2026 revenue of €25.5 million, down 8.3% year over year, as its core B2B distribution business fell 11% to €21.6 million. B2C and store-network revenue rose 5.6% and 17.8%, respectively. Commercial margin increased to 26.3% from 21.7%, while net profit rose 24.1% to €0.8 million. The company attributed the profitability improvement to catalog optimization, logistics restructuring and the ramp-up of Labster, its in-house production unit for proprietary brands.
Market
Sep.17 by 2Firsts Perspectives
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
Japan Tobacco International's Irish business has proposed a €0.25 tax increase on a pack of 20 cigarettes in its pre-Budget 2027 submission, below the €0.50-or-more increases typically imposed in recent Irish budgets. JTI says the proposal could generate around €45 million in additional Exchequer revenue while limiting further movement toward illicit and non-Irish-tax-paid tobacco. Revenue's existing estimate for a comparable €0.25 increase, including pro-rata rises on other tobacco products, is about €18 million for a full year.
JTI
Sep.18 by 2Firsts Perspectives
South Korean Lawmaker Jeong Jin-wook Pushes Synthetic Nicotine Vape Probe, Highlighting Supply Chain and Tax Concerns
South Korean Lawmaker Jeong Jin-wook Pushes Synthetic Nicotine Vape Probe, Highlighting Supply Chain and Tax Concerns
South Korean lawmaker Jeong Jin-wook has again called for stronger government action against liquid synthetic nicotine vape manufacturers and sellers, alleging that some businesses may have avoided regulation through product labeling changes and corporate restructuring. According to Newsworks, JNILBO and other Korean reports, Jeong has held his third press conference on the issue, calling for a government-wide investigation. The dispute involves whether synthetic nicotine products should fall under tobacco regulations, tax implications and supply-chain transparency. South Korean government agencies have previously said some estimates of potential tax losses cannot be verified due to limited sales data.
Jul.27
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Philip Morris International has published its first report aligned with the Taskforce on Nature-related Financial Disclosures, bringing its electronics supply chain and the use and end-of-life stages of smoke-free devices and consumables into its nature-related assessment. PMI said its smoke-free business accounted for about 42% of total net revenues in the second quarter of 2026. The report says non-circular electronic products, particularly single-use items, can increase consumption of limited natural resources and also details an IQOS repair pilot. A 2040 circularity scenario tests assumptions including a 50% reduction in product waste-related costs, 10% raw-material savings and a 25% substitution rate for refurbished products versus new products.
Sep.23
2Firsts Hosts U.S. Market Mid-Year Briefing: Companies Need to Reassess Product and Market-Access Strategies
2Firsts Hosts U.S. Market Mid-Year Briefing: Companies Need to Reassess Product and Market-Access Strategies
2Firsts held its 2026 U.S. Market Compliance and Development Mid-Year Briefing in Shenzhen, China, on July 28. The discussion examined how state-level requirements, proposed foreign-establishment registration rules and expanding supply-chain responsibilities are changing product and investment decisions in the U.S. tobacco and nicotine market.
Jul.29
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As regulators pay closer attention to child safety in nicotine pouches, manufacturers face a practical challenge: how to strengthen child-resistant packaging without unnecessarily reworking products, production lines and regulatory submissions already in place. In a written interview with 2Firsts, Chemular detailed Safeguard’s external packaging approach, its customer-specific testing requirements and possible PMTA pathways. The model remains early-stage, but it offers a new way to think about an increasingly important regulatory and manufacturing issue.
Industry Insight
Sep.19